Hostname: page-component-cd9895bd7-q99xh Total loading time: 0 Render date: 2024-12-25T04:14:44.407Z Has data issue: false hasContentIssue false
  • English
  • Français

Preterm Factors Influencing Surfactant Deficiency

Published online by Cambridge University Press:  10 March 2009

Alan H. Jobe
Alan H. Jobe
Affiliation:
Harbor–UCLA Medical Center, Torrance
Get access Rights & Permissions [Opens in a new window]

Extract

Surfactant deficiency has come to be understood as equivalent clinically to lung immaturity, except in situations of extreme prematurity or lung hypoplasia. Thus, surfactant deficiency and the diagnosis respiratory distress syndrome (RDS) have been applied quite uniformly to preterm infants with respiratory distress who have no other identifiable problems. While the diagnosis can be made more specific by assay of surfactant phospholipid composition (12), such measurements are seldom made in clinical practice. Perinatal discussions of the premature with respiratory distress also have been focused toward surfactant by the availability of multiple tests of “lung maturation” based on the assay of surfactant components in amniotic fluid (19). While surfactant is necessary for normal lung function, adequate surfactant is not sufficient to assure normal gas exchange in the preterm. There are no simple ways to separate surfactant deficiency states clearly from other aspects of lung development, such as airway development, alveolarization, and the development of the pulmonary vasculature in the preterm infant. The anatomic data of Hislop et al. (13) and Langston et al. (22) indicate a considerable variability in the number of alveoli in the preterm infant at each gestational age, resulting in large differences in potential gas exchange surfaces in different infants. Airway development also differs between infants of comparable gestational ages, as is evident clinically by susceptibility to the development of pulmonary interstitial emphysema. Assuming that surfactant treatments for RDS fully correct the surfactant deficiency, a realistic expectation based on animal studies (16), surfactant treatments should be useful in the near future to eliminate the surfactant deficiency component of lung immaturity syndromes. Any residual lung disease can then be better characterized.

Type
Neonatal Disorders of Respiration
Information
International Journal of Technology Assessment in Health Care , Volume 7 , Supplement S1 , January 1991 , pp. 16 - 20
Copyright
Copyright © Cambridge University Press 1991

Access options

Get access to the full version of this content by using one of the access options below. (Log in options will check for institutional or personal access. Content may require purchase if you do not have access.)

References

REFERENCES

1.Ballard, P. L.Hormones and lung maturation. Berlin: Springer-Verlag, 1986.CrossRefGoogle ScholarPubMed
2.Beck, J. C., Mitzner, W., Johnson, J. W. C., et al. Betamethasone and the rhesus fetus: Effect on lung morphometry and connective tissue. Pediatric Research, 1981, 15, 235–40.CrossRefGoogle ScholarPubMed
3.Clements, J. A., & Tooley, W. H. Kinetics of surface active material in the fetal lung. In Brown, W. A. (ed.), Development of the lung. New York: Marcel-Dekker, 1977, 349–66.Google Scholar
4.Collaborative Group on Antenatal Steroid Therapy. Effect of antenatal dexamethasone administration on the prevention of respiratory distress syndrome. American Journal of Obstetrics and Gynecology, 1981, 141, 246.Google Scholar
5.Ekelund, L., Burgoyne, R., & Enhorning, G.Pulmonary surfactant release in fetal rabbits: Immediate and delayed response to terbutaline. American Journal of Obstetrics and Gynecology, 1983, 147, 437–43.CrossRefGoogle ScholarPubMed
6.Elkady, T., & Jobe, A.Corticosteroids and surfactant increase lung volumes and decrease rupture pressures of preterm rabbit lungs. Journal of Applied Physiology, 1987, 63,1616–21.CrossRefGoogle ScholarPubMed
7.Faridy, E. E.Air opening pressure in fetal lungs. Respiratory Physiology, 1987, 68, 293–300.CrossRefGoogle ScholarPubMed
8.Fiascone, J. M., Jacobs, H. C., Moya, F. R., et al. Betamethasone increases pulmonary compliance in part by surfactant independent mechanisms in preterm rabbits. Pediatric Research, 1987, 22, 730–35.CrossRefGoogle ScholarPubMed
9.Frank, L., Lewis, P. L., & Sosenko, I. R. S.Dexamethasone stimulation of fetal rat lung antioxidant enzyme activity in parallel with surfactant stimulation. Pediatrics, 1985, 75, 569–74.Google ScholarPubMed
10.Freese, W. B., & Hallman, M.The effect of betamethasone and fetal sex on the synthesis and maturation of lung surfactant phospholipids in rabbits. Biochim Biophysics Acta, 1983, 750, 47–59.CrossRefGoogle ScholarPubMed
11.Gonzales, L. W., Ballard, P. L., Ertsey, R., et al. Glucocorticoids and thyroid hormones stimulate biochemical and morphological differentiation of human fetal lung in organ culture. Journal of Clinical Endocrinology and Metabolism, 1986, 62, 678–91.CrossRefGoogle ScholarPubMed
12.Hallman, M., Feldman, B. H., Kirkpatric, E., & Gluck, L.Absence of phosphatidylglycerol in respiratory distress syndrome in the newborn. Pediatric Research, 1977, 11, 714–20.CrossRefGoogle ScholarPubMed
13.Hislop, A. A., Wigglesworth, J. S., & Desai, R.Alveolar development in the human fetus and infant. Early Human Development, 1986, 13, 1–11.CrossRefGoogle ScholarPubMed
14.Ikegami, M., Berry, D., Elkady, T., et al. Corticosteroids and surfactant change lung function and protein leaks in the lungs of ventilated premature rabbits. Journal of Clinical Investigation, 1987, 79, 1371–78.CrossRefGoogle ScholarPubMed
15.Ikegami, M., Jobe, A. H., Pettanazzo, A., et al. Effect of maternal treatment with corticosteroids, T2, TRH and their combinations on lung function of ventilated preterm rabbits with and without surfactant treatments. American Review of Respiratory Disease, 1987, 136, 892–98.CrossRefGoogle Scholar
16.Jobe, A., & Ikegami, M.Surfactant for the treatment of respiratory distress syndrome. American Review of Respiratory Disease, 1987, 136, 1256–75.CrossRefGoogle ScholarPubMed
17.Kaufman, S. L.Acceleration of canalicular development in lungs of fetal mice exposed transplacentally to dexamethasone. Laboratory Investigation, 1977, 36, 395–401.Google Scholar
18.Kotas, R. V., & Avery, M. E.Accelerated appearance of pulmonary surfactant in the fetal rabbit. Journal of Applied Physiology, 1971, 30, 358–61.CrossRefGoogle ScholarPubMed
19.Kulovich, M. V., Hallman, M. B., & Gluck, L.The lung profile. I. Normal pregnancy. American Journal of Obstetrics and Gynecology, 1979, 135, 57–63.CrossRefGoogle ScholarPubMed
20.Kwong, M., & Egan, E. A.Reduced incidence of hyaline membrane disease in extremely premature infants following delay in delivery in mothers with preterm labor: use of ritodrine and betamethasone. Pediatrics, 1986, 78, 767–74.CrossRefGoogle ScholarPubMed
21.Kwong, M., Egan, E., & Notter, R.Synergistic response of antenatal betamethasone and tracheal instillation of calf lung surfactant extract (CLSE) at birth. Pediatric Research, 1987, 21, 458A.Google Scholar
22.Langston, C., Kida, K., Reed, M., & Thurlbeck, W. M.Human lung growth in late gestation and in the neonate. American Review of Respiratory Disease, 1984, 129, 607–13.Google ScholarPubMed
23.Liggins, G. C.Premature delivery of foetal lambs infused with glucocorticoids. Journal of Endocrinology, 1969, 45, 515–23.CrossRefGoogle ScholarPubMed
24.Liggins, G. C., & Howie, R. N.A controlled trial of antepartum glucocorticoid treatment for prevention of the respiratory distress syndrome in premature infants. Pediatrics, 1972, 50, 515–25.CrossRefGoogle ScholarPubMed
25.Liggins, G. C., & Schellenberg, J. C. Hormones and lung maturation. Respiratory control and lung development in the fetus and newborn. In Johnson, B. M. and Gluckman, P. D. (eds.), Perinatology Pres, 1986, 107–33.Google Scholar
26.Maniscalco, W. M., & Shapiro, D. L.Effects of dexamethasone on beta-adrenergic receptors in fetal lung explants. Pediatric Research, 1983, 17, 274–77.CrossRefGoogle ScholarPubMed
27.Rooney, S. A.The surfactant system and lung phospholipid biochemistry. American Review of Respiratory Disease, 1985, 131, 439–60.Google ScholarPubMed
28.Rooney, S. A., Gobran, L. I., & Chu, A. J.Thyroid hormone opposes some glucocorticoid effects on glycogen content and lipid synthesis in developing fetal rat lung. Pediatric Research, 1986, 20, 545–50.CrossRefGoogle ScholarPubMed
29.Seidner, S., Pettenazzo, A., Ikegami, M., & Jobe, A. Potentiation of dose response relationships of surfactant in preterm rabbits following maternal corticosteroid treatments. Journal of Applied Physiology, 1988, in press.Google Scholar
30.Warburton, D., Parton, L., Buckley, S., et al. Combined effects of corticosteroid, thyroid hormones and beta-agonist on surfactant, pulmonary mechanics and beta receptor binding in fetal lamb lung. Pediatric Research, 1988, 24, 166–70.CrossRefGoogle ScholarPubMed